SE8404707L - Komposition innehallande pyridinlosligt extrakt och raffinerat detoxifierat endotoxin samt anvendning derav - Google Patents

Komposition innehallande pyridinlosligt extrakt och raffinerat detoxifierat endotoxin samt anvendning derav

Info

Publication number
SE8404707L
SE8404707L SE8404707A SE8404707A SE8404707L SE 8404707 L SE8404707 L SE 8404707L SE 8404707 A SE8404707 A SE 8404707A SE 8404707 A SE8404707 A SE 8404707A SE 8404707 L SE8404707 L SE 8404707L
Authority
SE
Sweden
Prior art keywords
extract
insulated
composition containing
detoxified endotoxin
containing pyridine
Prior art date
Application number
SE8404707A
Other languages
English (en)
Swedish (sv)
Other versions
SE8404707D0 (sv
Inventor
J L Cantrell
Original Assignee
Ribi Immunochem Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ribi Immunochem Research Inc filed Critical Ribi Immunochem Research Inc
Publication of SE8404707D0 publication Critical patent/SE8404707D0/xx
Publication of SE8404707L publication Critical patent/SE8404707L/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • A61K2039/585—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation wherein the target is cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8404707A 1983-09-23 1984-09-20 Komposition innehallande pyridinlosligt extrakt och raffinerat detoxifierat endotoxin samt anvendning derav SE8404707L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/535,037 US4663306A (en) 1983-09-23 1983-09-23 Pyridine-soluble extract-refined detoxified endotoxin composition and use

Publications (2)

Publication Number Publication Date
SE8404707D0 SE8404707D0 (sv) 1984-09-20
SE8404707L true SE8404707L (sv) 1985-03-24

Family

ID=24132594

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8404707A SE8404707L (sv) 1983-09-23 1984-09-20 Komposition innehallande pyridinlosligt extrakt och raffinerat detoxifierat endotoxin samt anvendning derav

Country Status (23)

Country Link
US (1) US4663306A (OSRAM)
JP (1) JPS60120817A (OSRAM)
KR (1) KR870000843B1 (OSRAM)
AT (1) AT385659B (OSRAM)
AU (1) AU566234B2 (OSRAM)
BE (1) BE900650A (OSRAM)
CA (1) CA1244765A (OSRAM)
CH (1) CH664897A5 (OSRAM)
DE (1) DE3434766C2 (OSRAM)
DK (1) DK446684A (OSRAM)
ES (1) ES8608872A1 (OSRAM)
FI (1) FI843716A7 (OSRAM)
FR (1) FR2552326B1 (OSRAM)
GB (1) GB2149301B (OSRAM)
HU (1) HU192585B (OSRAM)
IL (1) IL73034A (OSRAM)
IN (1) IN157240B (OSRAM)
IT (1) IT1179444B (OSRAM)
NL (1) NL8402902A (OSRAM)
NO (1) NO843776L (OSRAM)
NZ (1) NZ209635A (OSRAM)
SE (1) SE8404707L (OSRAM)
ZA (1) ZA847405B (OSRAM)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4844894A (en) * 1984-07-12 1989-07-04 Ribi Immunochem Research Inc. Method of inhibiting the onset of septicemia and endotoxemia
US4877611A (en) * 1986-04-15 1989-10-31 Ribi Immunochem Research Inc. Vaccine containing tumor antigens and adjuvants
US4806352A (en) * 1986-04-15 1989-02-21 Ribi Immunochem Research Inc. Immunological lipid emulsion adjuvant
US4929604A (en) * 1986-05-28 1990-05-29 Board Of Regents, The University Of Texas System Lipopolysaccharides of reduced toxicity and the production thereof
EP0714305B1 (en) * 1993-08-27 2001-12-19 Vetrepharm, Inc. Composition and method for stimulation of reproductive performance
BE1007823A3 (fr) * 1993-12-10 1995-10-31 Anda Biolog Sa Utilisation d'une composition comprenant au moins un antigene et/ou un ou plusieurs fragments de cet antigene pour l'obtention d'un medicament destine au traitement et/ou a la prevention du cancer.
US6090385A (en) * 1993-12-10 2000-07-18 Maes; Hubert Method of treating cancer
US5976580A (en) 1995-06-07 1999-11-02 Novus International, Inc. Nutrient formulation and process for enhancing the health, livability, cumulative weight gain or feed efficiency in poultry and other animals
DE19710255A1 (de) * 1997-03-13 1998-09-17 Henkel Ecolab Gmbh & Co Ohg Verwendung einer Lösung zur Desaktivierung von Endotoxinen
PT1003525E (pt) 1997-08-05 2003-03-31 Bioniche Life Sciences Inc Composicao e metodo para a regulacao da proliferacao e da morte celular
US6019985A (en) * 1998-02-27 2000-02-01 Munova Corporation Immunostimulation methods for providing disease protection in poultry
WO2000003724A1 (en) * 1998-07-16 2000-01-27 Hayashi, Akira Preparations for immunotherapy for cancer having bacterial somatic constituent as the active ingredient
DK1238070T3 (da) * 1999-12-13 2007-12-03 Bioniche Life Sciences Inc Terapeutisk anvendelige syntetiske oligonucleotider
EP1250152B1 (en) * 1999-12-28 2013-05-15 Bioniche Urology IP Inc. Synergistic composition containing hyaluronic acid in the treatment of cancer
SI21171A (sl) * 2000-07-11 2003-10-31 Bayer Aktiengesellschaft Uporaba sevov parapoksvirusa ovis proti fibrozi organov
CA2478106A1 (en) * 2002-03-05 2003-09-12 Cell-Medicine, Inc. Solidified tissue immunoadjuvant
WO2004012751A1 (ja) * 2002-08-02 2004-02-12 Sumitomo Pharmaceuticals Company, Limited 細菌細胞壁骨格成分製剤
FR2848223B1 (fr) * 2002-12-09 2005-02-25 Centre Nat Rech Scient Nouveau procede d'isolement des endotoxines.
US20060127518A1 (en) * 2003-09-05 2006-06-15 Shenyang Sunbellcom Bio-Pharmaceutical Co. Red nocardia cell wall skeleton preparation process and its therapeutic use on treating cervical erosion
US20080032384A1 (en) * 2004-04-22 2008-02-07 Takehiko Nomura Pharmaceutical Preparation Containing Bacterial Cell Wall Skeleton
EP2986303B1 (en) 2013-04-18 2020-02-26 Immune Design Corp. Gla monotherapy for use in cancer treatment
US9463198B2 (en) 2013-06-04 2016-10-11 Infectious Disease Research Institute Compositions and methods for reducing or preventing metastasis
CA2950945A1 (en) 2014-06-17 2015-12-23 Xycrobe Therapeutics, Inc. Genetically modified bacteria and methods for genetic modification of bacteria
WO2017147507A1 (en) 2016-02-24 2017-08-31 Xycrobe Therapeutics, Inc. Skin probiotic formulation
US20210040055A1 (en) * 2017-08-17 2021-02-11 University Of Delaware Furan based compositions and methods of making thereof
WO2021262622A1 (en) 2020-06-23 2021-12-30 Crown Laboratories, Inc. Probiotic skin formulations

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7308450A (OSRAM) * 1972-06-20 1973-12-27
FR2269962B1 (OSRAM) * 1974-05-06 1978-02-03 Anvar
JPS58874B2 (ja) * 1979-08-30 1983-01-08 株式会社 目黒研究所 糖蛋白ｗｅｎａｃ及びその製造法
US4436728A (en) * 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US4435386A (en) * 1982-05-26 1984-03-06 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US4436727A (en) * 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
CA1206416A (en) * 1982-06-30 1986-06-24 John L. Cantrell Pyridine soluble extract of a microorganism
CA1206415A (en) * 1982-06-30 1986-06-24 John L. Cantrell Pyridine soluble extract of a microorganism
CA1209504A (en) * 1982-06-30 1986-08-12 John L. Cantrell Pyridine soluble extract of a microorganism

Also Published As

Publication number Publication date
FI843716L (fi) 1985-03-24
ZA847405B (en) 1985-05-29
FI843716A0 (fi) 1984-09-21
US4663306A (en) 1987-05-05
GB8423993D0 (en) 1984-10-31
IL73034A (en) 1988-11-15
FR2552326A1 (fr) 1985-03-29
DE3434766A1 (de) 1986-04-30
JPS6254775B2 (OSRAM) 1987-11-17
AT385659B (de) 1988-05-10
HU192585B (en) 1987-06-29
JPS60120817A (ja) 1985-06-28
NO843776L (no) 1985-03-25
ATA302384A (de) 1987-10-15
IT8448894A0 (it) 1984-09-24
IN157240B (OSRAM) 1986-02-15
CH664897A5 (de) 1988-04-15
AU3340084A (en) 1985-03-28
DK446684A (da) 1985-03-24
HUT35521A (en) 1985-07-29
SE8404707D0 (sv) 1984-09-20
KR870000843B1 (ko) 1987-04-25
FR2552326B1 (fr) 1988-05-13
ES8608872A1 (es) 1986-07-16
NZ209635A (en) 1989-01-27
GB2149301B (en) 1988-06-22
BE900650A (fr) 1985-03-21
DE3434766C2 (de) 1987-05-14
DK446684D0 (da) 1984-09-19
IT1179444B (it) 1987-09-16
ES536167A0 (es) 1986-07-16
KR850002404A (ko) 1985-05-13
AU566234B2 (en) 1987-10-15
GB2149301A (en) 1985-06-12
FI843716A7 (fi) 1985-03-24
CA1244765A (en) 1988-11-15
NL8402902A (nl) 1985-04-16

Similar Documents

Publication Publication Date Title
SE8404707D0 (sv) Komposition innehallande pyridinlosligt extrakt och raffinerat detoxifierat endotoxin samt anvendning derav
IT8048102A0 (it) Procedimento di preparazione di un idrolisato di proteine purificato
BE893803A (fr) Schoen voor atleten
DK173883D0 (da) Substituerede 8-phenylxanthiner
SE7908494L (sv) Dekorativ enhet och sett for framstellning derav
IT7968973A0 (it) Trinciatrice per la distruzione di documenti
ES499227A0 (es) Procedimiento para la determinacion de antigenos carcinoem- brionicos en el plasma humano
IT8323773U1 (it) Mezzi di guida per l'estrazione di cassetti o simili
IT7924778A0 (it) Procedimento per l'innesto di particelle di gomma dienica in emulsione.
IT1126621B (it) Gabbia per stabulazione di animali e di topi in particolare
IT1223529B (it) Epitopo immunodominante protettivo contenuto nella subunita' s1 della tossina della pertosse
NO834408L (no) Neisseria gonorrhoeae-vaksine
FR2550945B1 (fr) Compositions d'endotoxines purifiees et leur application pharmacologique
IT1110814B (it) Sistema di traversine per binari e procedimento per la fabbricazione dello stesso
DE3750642D1 (de) Verfahren und Zusammensetzungen betreffend regressions-assoziierte Antigene.
DE3262037D1 (de) 17-cyclopropylmethyl-3-hydroxy-14-methoxy 7 alpha-methylmorphinan-6-one
NL194960B (nl) Werkwijze voor het bereiden van mutantstammen van Bordetella bronchiseptica en daarop gebaseerd levend verzwakt vaccin.
ES513956A0 (es) "procedimiento para la carbonilacion de olefinas y esteres organicos".
PT85284A (fr) Procede de preparation de fractions antigeniques exocellulaires de bordetella pertussis et vaccin contre la co-ueluche contenant de telles fractions
NL7902162A (nl) Voorversterkers voor kleurentelevisiekamera's.
IT8125642A0 (it) Procedimento per la duplicazione di sagome e finiture.
IT1120568B (it) Trappola per topi e simili
IT1119156B (it) Procedimento per la preparazione di 2 alcossi 4 6 dicloro s triazine
FI820633L (fi) Eldfast byggnadssten foer framstaellning av inre skalet och ine blocket i en med dubbla skal foersedd kakelugn
DK212083A (da) Antigenisk peptidforbindelse

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8404707-5

Effective date: 19900401